Selected research
Industry Research
Enzyme Markers Industry Research Report 2026
Market perspective
The global Enzyme Markers market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Enzyme Markers is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Enzyme Markers is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Enzyme Markers is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Enzyme Markers include Takeda Pharmaceutical Company Limited, Sanofi, Merck, Thermo Fisher Scientific Inc., Promega Corporation, Nutritech, Novozymes, Genzyme Corporation and DuPont Danisco, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Enzyme Markers market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Enzyme Markers Market by Company
Takeda Pharmaceutical Company Limited
Sanofi
Merck
Thermo Fisher Scientific Inc.
Promega Corporation
Nutritech
Novozymes
Genzyme Corporation
DuPont Danisco
Danaher (Cytiva)
BASF
Asahi Kasei Corporation
Amway
Amano Enzyme Inc
Agilent Technologies Inc.
Abcam
AB Enzymes
Enzyme Markers Segment by Type
5'-nucleotidase
N-acetyl-beta-glucosaminidase
Acetate dehydrogenase
Catalase
Neutral alpha-glucosidase
Enzyme Markers Segment by Application
Diagnostic tests
Drug Development
Clinical Trails
Enzyme Markers Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzyme Markers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enzyme Markers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzyme Markers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Enzyme Markers manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Enzyme Markers by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Enzyme Markers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5'-nucleotidase
- N-acetyl-beta-glucosaminidase
- Acetate dehydrogenase
- Catalase
- Neutral alpha-glucosidase
Applications
- Diagnostic tests
- Drug Development
- Clinical Trails
Companies covered
- Takeda Pharmaceutical Company Limited
- Sanofi
- Merck
- Thermo Fisher Scientific Inc.
- Promega Corporation
- Nutritech
- Novozymes
- Genzyme Corporation
- DuPont Danisco
- Danaher (Cytiva)
- BASF
- Asahi Kasei Corporation
- Amway
- Amano Enzyme Inc
- Agilent Technologies Inc.
- Abcam
- AB Enzymes
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Enzyme Markers Market Size (2021-2032)
- 2.2.2 Global Enzyme Markers Sales (2021-2032)
- 2.2.3 Global Enzyme Markers Market Average Price (2021-2032)
- 2.3 Enzyme Markers by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 5'-nucleotidase
- 2.3.3 N-acetyl-beta-glucosaminidase
- 2.3.4 Acetate dehydrogenase
- 2.3.5 Catalase
- 2.3.6 Neutral alpha-glucosidase
- 2.4 Enzyme Markers by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Diagnostic tests
- 2.4.3 Drug Development
- 2.4.4 Clinical Trails
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Enzyme Markers Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Enzyme Markers Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Enzyme Markers Revenue of Manufacturers (2021-2026)
- 3.4 Global Enzyme Markers Average Price by Manufacturers (2021-2026)
- 3.5 Global Enzyme Markers Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Enzyme Markers, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Enzyme Markers, Product Type & Application
- 3.8 Global Manufacturers of Enzyme Markers, Established Date
- 3.9 Global Enzyme Markers Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Takeda Pharmaceutical Company Limited
- 4.1.1 Takeda Pharmaceutical Company Limited Company Information
- 4.1.2 Takeda Pharmaceutical Company Limited Business Overview
- 4.1.3 Takeda Pharmaceutical Company Limited Enzyme Markers Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Takeda Pharmaceutical Company Limited Enzyme Markers Product Portfolio
- 4.1.5 Takeda Pharmaceutical Company Limited Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Enzyme Markers Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Enzyme Markers Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Merck
- 4.3.1 Merck Company Information
- 4.3.2 Merck Business Overview
- 4.3.3 Merck Enzyme Markers Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Enzyme Markers Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 Thermo Fisher Scientific Inc.
- 4.4.1 Thermo Fisher Scientific Inc. Company Information
- 4.4.2 Thermo Fisher Scientific Inc. Business Overview
- 4.4.3 Thermo Fisher Scientific Inc. Enzyme Markers Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Thermo Fisher Scientific Inc. Enzyme Markers Product Portfolio
- 4.4.5 Thermo Fisher Scientific Inc. Recent Developments
- 4.5 Promega Corporation
- 4.5.1 Promega Corporation Company Information
- 4.5.2 Promega Corporation Business Overview
- 4.5.3 Promega Corporation Enzyme Markers Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Promega Corporation Enzyme Markers Product Portfolio
- 4.5.5 Promega Corporation Recent Developments
- 4.6 Nutritech
- 4.6.1 Nutritech Company Information
- 4.6.2 Nutritech Business Overview
- 4.6.3 Nutritech Enzyme Markers Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Nutritech Enzyme Markers Product Portfolio
- 4.6.5 Nutritech Recent Developments
- 4.7 Novozymes
- 4.7.1 Novozymes Company Information
- 4.7.2 Novozymes Business Overview
- 4.7.3 Novozymes Enzyme Markers Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Novozymes Enzyme Markers Product Portfolio
- 4.7.5 Novozymes Recent Developments
- 4.8 Genzyme Corporation
- 4.8.1 Genzyme Corporation Company Information
- 4.8.2 Genzyme Corporation Business Overview
- 4.8.3 Genzyme Corporation Enzyme Markers Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Genzyme Corporation Enzyme Markers Product Portfolio
- 4.8.5 Genzyme Corporation Recent Developments
- 4.9 DuPont Danisco
- 4.9.1 DuPont Danisco Company Information
- 4.9.2 DuPont Danisco Business Overview
- 4.9.3 DuPont Danisco Enzyme Markers Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 DuPont Danisco Enzyme Markers Product Portfolio
- 4.9.5 DuPont Danisco Recent Developments
- 4.10 Danaher (Cytiva)
- 4.10.1 Danaher (Cytiva) Company Information
- 4.10.2 Danaher (Cytiva) Business Overview
- 4.10.3 Danaher (Cytiva) Enzyme Markers Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Danaher (Cytiva) Enzyme Markers Product Portfolio
- 4.10.5 Danaher (Cytiva) Recent Developments
- 4.11 BASF
- 4.11.1 BASF Company Information
- 4.11.2 BASF Business Overview
- 4.11.3 BASF Enzyme Markers Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 BASF Enzyme Markers Product Portfolio
- 4.11.5 BASF Recent Developments
- 4.12 Asahi Kasei Corporation
- 4.12.1 Asahi Kasei Corporation Company Information
- 4.12.2 Asahi Kasei Corporation Business Overview
- 4.12.3 Asahi Kasei Corporation Enzyme Markers Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Asahi Kasei Corporation Enzyme Markers Product Portfolio
- 4.12.5 Asahi Kasei Corporation Recent Developments
- 4.13 Amway
- 4.13.1 Amway Company Information
- 4.13.2 Amway Business Overview
- 4.13.3 Amway Enzyme Markers Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Amway Enzyme Markers Product Portfolio
- 4.13.5 Amway Recent Developments
- 4.14 Amano Enzyme Inc
- 4.14.1 Amano Enzyme Inc Company Information
- 4.14.2 Amano Enzyme Inc Business Overview
- 4.14.3 Amano Enzyme Inc Enzyme Markers Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Amano Enzyme Inc Enzyme Markers Product Portfolio
- 4.14.5 Amano Enzyme Inc Recent Developments
- 4.15 Agilent Technologies Inc.
- 4.15.1 Agilent Technologies Inc. Company Information
- 4.15.2 Agilent Technologies Inc. Business Overview
- 4.15.3 Agilent Technologies Inc. Enzyme Markers Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Agilent Technologies Inc. Enzyme Markers Product Portfolio
- 4.15.5 Agilent Technologies Inc. Recent Developments
- 4.16 Abcam
- 4.16.1 Abcam Company Information
- 4.16.2 Abcam Business Overview
- 4.16.3 Abcam Enzyme Markers Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Abcam Enzyme Markers Product Portfolio
- 4.16.5 Abcam Recent Developments
- 4.17 AB Enzymes
- 4.17.1 AB Enzymes Company Information
- 4.17.2 AB Enzymes Business Overview
- 4.17.3 AB Enzymes Enzyme Markers Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 AB Enzymes Enzyme Markers Product Portfolio
- 4.17.5 AB Enzymes Recent Developments
5 Global Enzyme Markers Market Scenario by Region
- 5.1 Global Enzyme Markers Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Enzyme Markers Sales by Region: 2021-2032
- 5.2.1 Global Enzyme Markers Sales by Region: 2021-2026
- 5.2.2 Global Enzyme Markers Sales by Region: 2027-2032
- 5.3 Global Enzyme Markers Revenue by Region: 2021-2032
- 5.3.1 Global Enzyme Markers Revenue by Region: 2021-2026
- 5.3.2 Global Enzyme Markers Revenue by Region: 2027-2032
- 5.4 North America Enzyme Markers Market Facts & Figures by Country
- 5.4.1 North America Enzyme Markers Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Enzyme Markers Sales by Country (2021-2032)
- 5.4.3 North America Enzyme Markers Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Enzyme Markers Market Facts & Figures by Country
- 5.5.1 Europe Enzyme Markers Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Enzyme Markers Sales by Country (2021-2032)
- 5.5.3 Europe Enzyme Markers Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Enzyme Markers Market Facts & Figures by Country
- 5.6.1 Asia Pacific Enzyme Markers Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Enzyme Markers Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Enzyme Markers Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Enzyme Markers Market Facts & Figures by Country
- 5.7.1 South America Enzyme Markers Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Enzyme Markers Sales by Country (2021-2032)
- 5.7.3 South America Enzyme Markers Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Enzyme Markers Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Enzyme Markers Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Enzyme Markers Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Enzyme Markers Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Enzyme Markers Sales by Type (2021-2032)
- 6.1.1 Global Enzyme Markers Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Enzyme Markers Sales Market Share by Type (2021-2032)
- 6.2 Global Enzyme Markers Revenue by Type (2021-2032)
- 6.2.1 Global Enzyme Markers Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Enzyme Markers Revenue Market Share by Type (2021-2032)
- 6.3 Global Enzyme Markers Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Enzyme Markers Sales by Application (2021-2032)
- 7.1.1 Global Enzyme Markers Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Enzyme Markers Sales Market Share by Application (2021-2032)
- 7.2 Global Enzyme Markers Revenue by Application (2021-2032)
- 7.2.1 Global Enzyme Markers Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Enzyme Markers Revenue Market Share by Application (2021-2032)
- 7.3 Global Enzyme Markers Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Enzyme Markers Value Chain Analysis
- 8.1.1 Enzyme Markers Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Enzyme Markers Production Mode & Process
- 8.2 Enzyme Markers Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Enzyme Markers Distributors
- 8.2.3 Enzyme Markers Customers
9 Global Enzyme Markers Analyzing Market Dynamics
- 9.1 Enzyme Markers Industry Trends
- 9.2 Enzyme Markers Industry Drivers
- 9.3 Enzyme Markers Industry Opportunities and Challenges
- 9.4 Enzyme Markers Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst